126 related articles for article (PubMed ID: 34817331)
1. Effect of triptolide and chemotherapy on carcinoembryonic and carbohydrate antigens levels and first-line treatment of recurrent nasopharyngeal carcinoma.
Liu C; Yuan X; Liu X; Liang K; Ni Z; Yu G; Zhu L
Cell Mol Biol (Noisy-le-grand); 2021 Aug; 67(2):109-113. PubMed ID: 34817331
[TBL] [Abstract][Full Text] [Related]
2. [Phase II clinical trial of two different modes of administration of the induction chemotherapy for locally advanced nasopharyngeal carcinoma].
Bi T; Jin F; Wu W; Long J; Li Y; Gong X; Luo X; Li Z; He Q; Qu B
Zhonghua Zhong Liu Za Zhi; 2015 Sep; 37(9):676-81. PubMed ID: 26813432
[TBL] [Abstract][Full Text] [Related]
3. Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma.
Chen C; Zhou Y; Zhang X; Fu S; Lin Z; Fang W; Yang Y; Huang Y; Zhao H; Hong S; Zhang L
Cancer Med; 2020 Mar; 9(5):1721-1732. PubMed ID: 31955525
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.
Jiang Y; Song B; Chen Z
Comput Math Methods Med; 2022; 2022():5936773. PubMed ID: 35693259
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era.
Li PJ; Mo HY; Luo DH; Hu WH; Jin T
Oral Oncol; 2018 Oct; 85():95-100. PubMed ID: 30220326
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary result of multi-center clinical trial on the docetaxel, 5-Fu and DDP in the treatment of advanced, recurrent or metastatic nasopharyngeal carcinoma].
Huang HQ; Cai QQ; Lin XB; Wang AL; Bu Q; Hu XH; Pan ZH; Li YH; Shuang YR; Guan ZZ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):314-6. PubMed ID: 18788641
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of Yanshu injection (a compound Chinese traditional medicine) combined with concurrent radiochemotherapy in patients with stage III nasopharyngeal carcinoma].
Wei R; Yang DY; Jiang WZ; Dai YY; Wan LY; Yang Z
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):391-4. PubMed ID: 21875474
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma].
Han SH; Yu L; Zhang Z; Zhang PJ; Song HP; Guo CY
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):623-6. PubMed ID: 24314223
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of follow-up results of chrono-chemotherapy or conventional chemotherapy combined with intensity modulated radiotherapy in locally advanced nasopharyngeal carcinoma].
Liu KQ; Jin F; Jiang H; Wu WL; Li YY; Long JH; Luo XL; Gong XY; Chen XX; Liu LN; Gan JY; Zhou JJ
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):133-138. PubMed ID: 32135648
[No Abstract] [Full Text] [Related]
10. Efficacy of apatinib combined with tegafur gimeracil and oteracil potassium in the second-line treatment of advanced gastric cancer.
Chen H; Xue L; Liu L; Li P
J BUON; 2021; 26(3):917-923. PubMed ID: 34268954
[TBL] [Abstract][Full Text] [Related]
11. Is Immune Therapy Plus Chemotherapy More Effective Than Immune Therapy Alone for Unresectable Recurrent Nasopharyngeal Carcinoma?
Zhou X; Niu X; Liu P; Ou D; Zhu Y; Wang X
Front Immunol; 2021; 12():762663. PubMed ID: 34777379
[TBL] [Abstract][Full Text] [Related]
12. [A comparative study of long-term effects between induction chemotherapy and concurrent chemotherapy on patients with local advanced nasopharyngeal carcinoma].
Wang HB; Chen Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):361-365. PubMed ID: 29871262
[No Abstract] [Full Text] [Related]
13. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.
Al-Amro A; Al-Rajhi N; Khafaga Y; Memon M; Al-Hebshi A; El-Enbabi A; El-Husseiny G; Radawi A; Belal A; Allam A; El-Sebaie M
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):508-13. PubMed ID: 15890594
[TBL] [Abstract][Full Text] [Related]
14. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
[TBL] [Abstract][Full Text] [Related]
15. The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis.
Zhi-Qiang W; Qi M; Ji-Bin L; Rui Y; You-Ping L; Rui S; Guang-Yuan H; Ming-Yuan C; Yi-Jun H
BMC Cancer; 2019 Nov; 19(1):1122. PubMed ID: 31744469
[TBL] [Abstract][Full Text] [Related]
16. [Late course conformal radiotherapy combined with chemotherapy for stage III and IV a nasopharyngeal carcinoma].
Wu H; Lin Q; Yu ZH; Yang ZX; Feng LP
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1778-80. PubMed ID: 16253169
[TBL] [Abstract][Full Text] [Related]
17. Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Du C; Ying H; Zhou J; Hu C; Zhang Y
Int J Clin Oncol; 2013 Jun; 18(3):464-71. PubMed ID: 22527846
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma.
Peng PJ; Lv BJ; Tang C; Liao H; Lin Z; Liu YM; Wang ZH; Wang SY; Cheng ZB
Drug Des Devel Ther; 2015; 9():6401-5. PubMed ID: 26677316
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine Combined with Cisplatin Has a Better Effect in the Treatment of Recurrent/Metastatic Advanced Nasopharyngeal Carcinoma.
Yang Q; Nie YH; Cai MB; Li ZM; Zhu HB; Tan YR
Drug Des Devel Ther; 2022; 16():1191-1198. PubMed ID: 35502425
[TBL] [Abstract][Full Text] [Related]
20. Global longitudinal assessment of treatment outcomes in recurrent/metastatic nasopharyngeal carcinoma: GLANCE-NPC study.
Ahn MJ; Chirovsky D; Kuyas H; Auclair V; Abounit S; Joo S; Shah R; Yang MH
Future Oncol; 2021 Jun; 17(16):2015-2025. PubMed ID: 33601910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
